BioDuro-Sundia

Activities: Manufacturing

Trending Articles

  1. NHS, MHRA and Medicines UK launch Project Revive to tackle medicine shortages NHS England, the MHRA and Medicines UK have launched Project Revive, a collaborative pilot designed to address critical medicines shortages by fast-tracking dormant...
  2. Isopod Rapid Cleanrooms: the ideal elite controlled environment pod solution for Life Sciences and Engineering start-ups The Guardtech Group’s quick-assembly cleanroom pods combine superior performance, build quality and cost-effectiveness to give new applications the perfect platform to get...
  3. You need to be a subscriber to read this article.
    Click here to find out more.
    Delivering precision: why advanced therapies are redefining pharmaceutical logistics As advanced therapies narrow tolerances and personalise care, pharmaceutical logistics is being redefined as a precision-driven extension of treatment delivery, writes Michael...
  4. Nose-to-brain delivery outperforms systemic BBB technologies according to MetP Pharma The pioneering company has published preclinical data that strongly supports the advantages of its proprietary nose-to-brain drug delivery technology compared with systemic...
  5. AstraZeneca strengthens weight management pipeline with CSPC Pharmaceuticals collaboration The pair have signed a strategic collaboration covering eight obesity and type 2 diabetes programmes, including a clinical-ready GLP-1/GIP asset, AI-driven peptide discovery...

Upcoming event

High Shear = Mixing Success

19 February 2026 | Virtual See all

Related Content

Sustainability

BioDuro sites recognised with EcoVadis Gold and Silver sustainability certifications

Three of the CDMO's Chinese sites have been recognised for outstanding sustainability performance, highlighting BioDuro’s commitment to sustainability and its ongoing efforts to embed environmental and social responsibility into its business operations
Manufacturing

BioDuro launches dedicated peptide unit to boost global peptide drug discovery and GLP-1 development

The new business unit unifies BioDuro’s chemistry, biology, DMPK and manufacturing capabilities, accelerating end-to-end peptide therapeutic development for global biopharma partners
Pharmaceutical

BioDuro appoints Yaohui Ji as Global President, CMC to accelerate expansion of integrated CRDMO capabilities

BioDuro, a trusted global Contract Research, Development, and Manufacturing Organization (CRDMO), announced the appointment of Mr. Yaohui Ji as Global President, CMC

Christopher Conway joins BioDuro board

Appointment strengthens strategic leadership for global CRDMO
Pharma 5.0

BioDuro and Atombeat to launch an AI-powered platform for accelerated peptide drug discovery

BioDuro, a globally trusted CRDMO, and Atombeat, a leading force in AI for drug discovery, announce a strategic collaboration to deliver an AI-powered platform for accelerated peptide drug discovery
Research & Development

BioDuro and Silicogenix join forces to lower complex therapeutic development barriers

The companies plan to facilitate the rapid and cost-effective testing and development of complex therapeutic molecules
Sustainability

BioDuro gets emission reduction targets approved by the SBTi

The company has committed to reducing scope 1, 2 and 3 emissions, as well as increasing its use of renewable energy
Subscribe now